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Investigating the Impact of Sickle Cell Disease (SCD) on the 
Antenatal Experiences of Women in the United States
• 100,000 people are affected by Sickle Cell Disease in the 
United States (CDC, 2020)
– Occurs among 1 out of every 365 African American/Black 
births (CDC, 2020)
• 1 in 13 African American/Black babies are born with Sickle 
Cell Trait (CDC, 2020)
• Women with SCD are at greater risk of experiencing antenatal complications than 
women without SCD
– Increased vaso-occlusive crises, gestational hypertension, preeclampsia, eclampsia, 
stroke, preterm labor, miscarriage, and maternal death (Jain et al., 2019)
– Lack of research and discrepancies in medical recommendations for SCD treatment 
during pregnancy may contribute
• Women diagnosed with SCD will be significantly more likely to report antenatal complications compared to 
African American/ Black women without a history of hematologic disorders
• Women diagnosed with SCD will be significantly more likely to report anxiety and depression throughout 
their pregnancy compared to African American/ Black women without SCD
• Women diagnosed with SCD will be significantly more likely to report lower quality of prenatal care 
compared to African American/ Black women without SCD
HYPOTHESES
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